Skip to Main Content

Hello, everyone, and how are you today? We are doing just fine, thank you, now that the Pharmalot campus has quieted down. The short person is hovering over a laptop and Mrs. Pharmalot has taken the spirited official mascot for a long constitutional. As a result, we have time to focus on the necessary tasks, such as brewing cups of stimulation and foraging for items of interest. On that note, here are a few tidbits. By the way, the STAT Summit is in full swing, so you may want to take a peak. In any event, we hope your day is productive and meaningful. And stay safe — wear a mask. …

Pfizer (PFE) launched a pilot delivery program for its experimental Covid-19 vaccine in four U.S. states, as the drug maker seeks to address distribution challenges stemming from its ultra-cold storage requirements, Reuters notes. Rhode Island, Texas, New Mexico, and Tennessee were picked due to their differences in overall size, diversity of populations, immunization infrastructure, and urban and rural settings. The four states will not receive vaccine doses earlier than other states by virtue of the pilot, nor will they receive any differential consideration.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!